OpenAlex
PricingAboutJobs
Log inGet started
Author

Heini Lassus

Institutions: University of Helsinki, Helsinki University Hospital, Nordic Society of Gynecologic Oncology, Hospital District of Helsinki and Uusimaa
Observed institutions: University of Helsinki, Helsinki University Hospital, Nordic Society of Gynecologic Oncology, Hospital District of Helsinki and Uusimaa
OpenAlex ID: A5159529293
Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial
2026 · Domenica Lorusso, Jérôme Martin-Babau, et al. · The Lancet · 3
Length of Ischemic Time Is Critical for Accurate Determination of Homologous Recombination Capacity by Immunofluorescence Staining in Ovarian Cancer Formalin-Fixed Paraffin-Embedded Samples
2026 · Ezgi Karagöz, Sanna Pikkusaari, et al. · Archives of Pathology & Laboratory Medicine · 1
First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial
2026 · Brian M Slomovitz, Jianqing Zhu, et al. · The Lancet · 1
Works count: 3
Citation count: 5
H-index: 1
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security